Digital technologies are gaining ground in driving the transition to value-based healthcare, which rewards healthcare providers based on the quality, not quantity, of patient care. This is especially evident in orthopedics, where additive manufacturing innovations have led to major improvements in care efficiency and effectiveness.
The development of 3D-printed metal implants, using titanium, cobalt-chrome and stainless steel, is a prime example of how additive manufacturing has empowered surgeons to elevate patient outcomes. Leveraging additive manufacturing using the same materials and mechanical properties for traditional implants can create new, complex geometries and implants with pores into which connective tissue and bone can migrate. This concept, known as osseointegration, accelerates post-operative healing while enabling bone and implants to fuse better.
Not only does this improve implant fit, it simplifies surgeries, which traditionally required an extra step to apply special cement that connects the bone and implant. While this step is still part of conventional implants, it typically leads to longer surgeries, recoveries and higher incidence of implant failure when compared to 3D-printed implants.
The continued success of additive manufacturing has been reinforced by impressive performance increases at an order of magnitude higher than conventional procedures. The opportunity to also leverage 3D printing to produce a range of surgical instruments has created a groundswell for metal additive manufacturing.
Capacity Demands Intensify
According to industry sources, an increasingly significant of global implants will be produced using additive manufacturing in the very near future. At the annual Additive Manufacturing Strategies Conference in Boston on February 11-12, SmarTech Analysis’ latest study on additive manufacturing technologies in the orthopedic implant industry will be shared. Most notably, SmarTech projects this market to grow at 27 percent annually, which creates opportunities for incumbents and start-ups.
An important factor driving demand is the “graying” of the global population. People are living longer, and staying active later in life, so older adults increasingly are requesting implant surgeries. Another factor: The ease with which startups can take advantage of additive manufacturing to speed time-to-market with solutions that disrupt incumbent market share.
As competition heats up and barriers to market entry drop, conventional implant makers will be forced to cannibalize existing product lines to bring new 3D-printed versions to market faster. This need for speed is creating new market dynamics with a sense of urgency to scale rapidly.
Scaling capacity, however, is capital intensive, in terms of deploying metal 3D printers, post-processing processes as well as quality procedures capable of meeting strict medical regulations. While some organizations are trying to grow capacity internally, others are finding a faster route by partnering with manufacturing services providers with experience in regulated industries.
One of the biggest impediments to rapid scaling can be removed by partnering with a company that has expertise inhouse to apply the rigors of manufacturing to ensure repeatable process quality. Another barrier is having ample experience in integrating additive manufacturing materials, processes and machines to match specific part performance with application requirements. The ability to clear these hurdles is key to reducing time-to-market, cost and risk while producing the highest quality parts.
A Marathon Mindset
Adding 3D printing into the manufacturing mix isn’t a sprint, but the culmination of long-term planning, forecasting and plotting a path to personalization. It takes a marathon mindset and a “walk before you run” methodology to incorporate additive manufacturing into the healthcare landscape.
In addition to orthopedic implants, surgical instruments provide another viable entry point. They represent a low-volume, high-mix business, which is ideally suited for additive manufacturing. It’s highly common for two to three tables of surgical tools to be used during one implant procedure, so the business case to produce them using additive manufacturing is compelling. There’s typically high costs associated with producing these instruments, so implant OEMs often outsource the process.
Producing these instruments using additive manufacturing offers myriad benefits, not the least of which is tailoring “fit and feel” for a surgeon’s hands. Additionally, instrument designers have greater freedom to create a perfect match with a particular implant.
Ready, Set, Print
Ultimately, additive manufacturing will propel the entire industry toward more personalized healthcare with the ability to customize individual products while making it economically feasible to produce a single unit. That’s likely a phase two reality, following orthopedics spreading to other parts of medical manufacturing to transform the industry and take patient care to the next level.
It won’t happen overnight, but the race is on. It will be interesting to see which companies pull ahead of the pack to lead the way.
Geoffrey Doyle is Director of Business Development for Jabil Additive
You May Also Like
3D Printing News Briefs, October 9, 2021: Automation, Bioprinting, & More
We’re starting with new materials in today’s 3D Printing News Briefs, then moving on to automation, bioprinting, and business. B9Creations introduced new resins for 3D printed molds and production parts,...
Bioprinted Brain Cells Made Possible with Laser-Based 3D Printing
Scientists from the Université de Montréal have published a study detailing the ability to bioprint adult brain cells. Key to the research was a new laser-assisted technology that made it...
Cellink-Organovo Lawsuit Over Bioprinting Patents is Far From Over
In the highly competitive biotechnology and pharmaceutical industries, hardware manufacturers are under a lot of pressure to provide the best, most efficient, and fastest platforms for researchers. Bioprinting, in particular,...
Can Fluicell’s Bioprinted Tissue Help Treat Type 1 Diabetes?
As Swedish bioprinter manufacturer Fluicell prepares to enter the regenerative medicine market through its BioRej Advance program, it focuses on developing therapeutic products based on bioprinted transplantable microtissues targeting important...
View our broad assortment of in house and third party products.